  Patients with glioblastoma multiforme<pathogen> ( GBM) suffer from an increased incidence of vascular thrombotic events. However , key influencing factors of the primary hemostasis have not been characterized in GBM patients to date. Thus , the present study determines the activation level of circulating platelets in GBM patients ,